While CD4+ and CD8+ T-cell levels were not significantly correlated with clinical parameters, their presence and immune checkpoint expression emphasize their critical role in shaping DLBCL’s immunological landscape. This evidence concerns the gene CD4 and diffuse large B-cell lymphoma.